No Data
Intellia Therapeutics Q4 Net Loss Narrows; Shares Rise Pre-Bell
Intellia Therapeutics | 8-K: Intellia Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Company Progress
Earnings Flash (NTLA) Intellia Therapeutics Posts Q4 Collaboration Revenue $12.9M, Vs. FactSet Est of $8.6M
Earnings Flash (NTLA) Intellia Therapeutics Posts Q4 Net Loss $-1.27 a Share, Vs. FactSet Est of $-1.33 Loss
Express News | Intellia Therapeutics Q4 Basic EPS USD -1.27
Earnings Scheduled For February 27, 2025
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
DD07 : is it still an entry position